BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3274359)

  • 1. Promotion of tumor growth by blood transfusions.
    Singh SK; Marquet RL; de Bruin RW; Westbroek DL; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1473-4. PubMed ID: 3274359
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of blood transfusions and surgery on metastatic growth and immune parameters in a rat model.
    Marquet RL; Singh SK; Hoynck van Papendrecht MA; Jeekel J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):586-7. PubMed ID: 2705238
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood transfusion and surgery: the effect on growth of a syngeneic sarcoma.
    Parrott NR; Lennard TW; Proud G; Shenton BK; Givan A; White MD; Taylor R
    Ann R Coll Surg Engl; 1990 Mar; 72(2):77-81. PubMed ID: 2334101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-induced T suppressor cell activity and experimental tumor growth.
    Lenhard V; Scholler P; Zeller W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):580-3. PubMed ID: 2523151
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced growth of artificial tumor metastases following blood transfusion: the effect of erythrocytes, leukocytes and plasma transfusion.
    Singh SK; Marquet RL; Westbroek DL; Jeekel J
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1537-40. PubMed ID: 3678317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenetic control of metastatic competence of cloned tumor cell populations.
    Eisenbach L; De Baetselier P; Katzav S; Segal S; Feldman M
    Symp Fundam Cancer Res; 1983; 36():101-21. PubMed ID: 6332357
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunogenetic study of tumor growth in inbred rats].
    Urizar LA; Ballina JC; Amerio N; Morini JC; Rabasa SL
    Medicina (B Aires); 1982; 42(4):403-8. PubMed ID: 15171022
    [No Abstract]   [Full Text] [Related]  

  • 8. Mediation of immunity to tumor-specific transplantation antigens by RNA inhibition of isograft growth in rats.
    Deckers PJ; Pilch YH
    Cancer Res; 1972 Apr; 32(4):839-46. PubMed ID: 5014793
    [No Abstract]   [Full Text] [Related]  

  • 9. A preliminary investigation into the role of immunity in modifying the blood- borne spread of chemically induced rat sarcomas.
    Proctor JW; Rudenstam CM; Alexander P
    J Natl Cancer Inst; 1974 Dec; 53(6):1671-6. PubMed ID: 4373575
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.
    Liotta LA; Kleinerman J; Saidel GM
    Cancer Res; 1974 May; 34(5):997-1004. PubMed ID: 4841969
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of hypovolemia and transfusion on tumor growth in MCA-tumor-bearing rats.
    Younes RN; Rogatko A; Vydelingum NA; Brennan MF
    Surgery; 1991 Mar; 109(3 Pt 1):307-12. PubMed ID: 2000562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An experimental study of tumor growth and splenic histamine enzymes.
    Moore TC; Koppelmann LE; Lemmi CA
    Surg Gynecol Obstet; 1978 Apr; 146(4):559-66. PubMed ID: 205004
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of long-term rat renal allograft survival: a specific synergistic effect of limited pretransplant cyclosporine combined with multiple nonspecific blood transfusions.
    Martin DC; Hewitt CW; Black KS; Reyes M; Go C
    Transplant Proc; 1987 Feb; 19(1 Pt 1):462-3. PubMed ID: 3274807
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune responses to naturally occurring rat sarcomas.
    Embleton MJ; Middle JG
    Br J Cancer; 1981 Jan; 43(1):44-52. PubMed ID: 7459236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent fluctuations in quantities of circulating immune complexes during progressive and regressive phases of tumor growth.
    Jennette JC
    Am J Pathol; 1980 Aug; 100(2):403-10. PubMed ID: 7406017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to rat sarcomata. II. A syngeneic IgG2b antibody with anti-tumour activity.
    North SM; Dean CJ
    Immunology; 1983 Aug; 49(4):667-71. PubMed ID: 6874004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of clone formation in vivo using "epigenetic markers"].
    Vakhtin IuB; Ivashkevich LG; Shvemberger IN
    Tsitologiia; 1972 Jul; 14(7):884-9. PubMed ID: 4637821
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased tumour growth after blood transfusion.
    Clarke PJ; Wood KJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):584-5. PubMed ID: 2705237
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
    Isakov N; Feldman M; Segal S
    J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of blood loss on growth of artificial metastases.
    Singh SK; Marquet RL; de Bruin RW; Hop WC; Westbroek DL; Jeekel J
    Br J Surg; 1988 Apr; 75(4):377-9. PubMed ID: 3359155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.